CAAS Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-5,100
Closed -$580K 227
2024
Q1
$580K Buy
5,100
+600
+13% +$68.8K 0.04% 301
2023
Q4
$495K Sell
4,500
-14,700
-77% -$1.47M 0.05% 274
2023
Q3
$1.86M Sell
19,200
-11,800
-38% -$1.24M 0.12% 182
2023
Q2
$3.38M Buy
31,000
+2,900
+10% +$309K 0.23% 130
2023
Q1
$2.85M Sell
28,100
-7,000
-20% -$739K 0.15% 147
2022
Q4
$3.85M Buy
+35,100
New +$3.63M 0.23% 128
2021
Q1
Sell
-310,200
Closed -$34M 1125
2020
Q4
$34M Buy
310,200
+300,000
+2,941% +$32.6M 0.32% 61
2020
Q3
$1.11M Hold
10,200
0.03% 328
2020
Q2
$933K Buy
+10,200
New +$922K 0.03% 275

Other funds holding ABT

CAAS Capital Management's ABT Position: Q4 2023 in Review

CAAS Capital Management sold out of Abbott (ABT) in Q4 2023, closing a stake of 11,500 shares — an estimated $1.15M sold.

CAAS Capital Management first reported a position in ABT in Q2 2020 and held it in 5 quarters. The position peaked at $4.35M in Q2 2020. 2,886 funds tracked by Wall St. Rank hold ABT as of Q4 2023.

  • CAAS Capital Management reported no remaining Abbott position as of Q4 2023 after selling out during the quarter.
  • CAAS Capital Management sold 11,500 Abbott shares in Q4 2023, an estimated $1.15M.
  • CAAS Capital Management first reported a position in Abbott in Q2 2020 and held it in 5 quarters.
  • CAAS Capital Management's Abbott position peaked at $4.35M in Q2 2020.
  • 2,886 funds tracked by Wall St. Rank held Abbott as of Q4 2023.

Based on CAAS Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.